Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Sullivan

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 5, 2003
Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart StudyJohan Sundström, Lisa Sullivan, Ralph B D'Agostino, et al.
Circulation|July 25, 2007
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the communityRavi Dhingra, Lisa Sullivan, Paul F Jacques, et al.
Revista Espanola De Cardiologia|March 8, 2003
[Coronary risk estimation in Spain using a calibrated Framingham function]Jaume Marrugat, Pascual Solanas, Ralph D'Agostino, et al.
Obstetrics and Gynecology|July 2, 2008
Maternal thyroid hypofunction and pregnancy outcomeJane Cleary-Goldman, Fergal D Malone, Geralyn Lambert-Messerlian, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2017
Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid LesionsSogol Mostoufi-Moab, Emmanuel Labourier, Lisa Sullivan, et al.
European Heart Journal|March 25, 2004
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart StudyJohan Sundström, Lisa Sullivan, Jacob Selhub, et al.
JAMA Pediatrics|September 25, 2013
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trialBryan H King, Kimberly Dukes, Craig L Donnelly, et al.
Schizophrenia Research|September 3, 2005
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIIJoseph P McEvoy, Jonathan M Meyer, Donald C Goff, et al.
Contemporary Clinical Trials|January 25, 2019
Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trialHeather M Johnson, Lisa Sullivan-Vedder, KyungMann Kim, et al.
Archives of General Psychiatry|June 3, 2009
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismBryan H King, Eric Hollander, Linmarie Sikich, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Hypertension (Dallas, Tex. : 1979)|November 5, 2003
Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart StudyJohan Sundström, Lisa Sullivan, Ralph B D'Agostino, et al.
Circulation|July 25, 2007
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the communityRavi Dhingra, Lisa Sullivan, Paul F Jacques, et al.
Revista Espanola De Cardiologia|March 8, 2003
[Coronary risk estimation in Spain using a calibrated Framingham function]Jaume Marrugat, Pascual Solanas, Ralph D'Agostino, et al.
Obstetrics and Gynecology|July 2, 2008
Maternal thyroid hypofunction and pregnancy outcomeJane Cleary-Goldman, Fergal D Malone, Geralyn Lambert-Messerlian, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2017
Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid LesionsSogol Mostoufi-Moab, Emmanuel Labourier, Lisa Sullivan, et al.
European Heart Journal|March 25, 2004
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart StudyJohan Sundström, Lisa Sullivan, Jacob Selhub, et al.
JAMA Pediatrics|September 25, 2013
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trialBryan H King, Kimberly Dukes, Craig L Donnelly, et al.
Schizophrenia Research|September 3, 2005
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIIJoseph P McEvoy, Jonathan M Meyer, Donald C Goff, et al.
Contemporary Clinical Trials|January 25, 2019
Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trialHeather M Johnson, Lisa Sullivan-Vedder, KyungMann Kim, et al.
Archives of General Psychiatry|June 3, 2009
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismBryan H King, Eric Hollander, Linmarie Sikich, et al.
Pageof 7